MercadoLibre, Inc.
1,876.33USD
-49.9200 (-2.59%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $9.25▼ | $9.54 | 4 | 5 |
| Next quarter | $11.13▼ | $11.77 | 2 | 7 |
| Current year | $38.29▼ | $40.6 | 2 | 12 |
| Next year | $56.07▼ | $58.13 | 6 | 8 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $8.89 | $9.19 | +0.30 (+3.4%) |
| 2026-03-31 | $8.2 | $8.23 | +0.03 (+0.3%) |
| 2025-12-31 | $11.44 | $11.03 | -0.41 (-3.6%) |
| 2025-09-30 | $9.3 | $8.32 | -0.98 (-10.5%) |
307 ratings from 34 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BTIG | Reiterated | Buy | $2,150 | Sep 3, 2026 |
| JP Morgan | Maintained | Neutral | $1,900 $2,150 | Aug 11, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $2,150 $2,300 | Aug 6, 2026 |
| BTIG | Reiterated | Buy | $2,150 | Aug 6, 2026 |
| Citigroup | Maintained | Neutral | $1,950 $2,000 | Jul 15, 2026 |
| BTIG | Reiterated | Buy | $2,150 | Jun 2, 2026 |
| Citigroup | Downgraded from Buy | Neutral | $2,200 $1,950 | May 13, 2026 |
| JP Morgan | Maintained | Neutral | $2,100 $1,900 | May 13, 2026 |
| UBS | Maintained | Neutral | $2,050 $1,750 | May 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $2,600 $2,450 | May 11, 2026 |
| Barclays | Maintained | Overweight | $2,500 $2,300 | May 11, 2026 |
| Benchmark | Maintained | Buy | $2,780 $2,380 | May 8, 2026 |
| BTIG | Maintained | Buy | $2,400 $2,150 | May 8, 2026 |
| Scotiabank | Maintained | Sector Outperform | $3,500 $2,800 | May 7, 2026 |
| UBS | Downgraded from Buy | Neutral | $2,700 $2,050 | Apr 29, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $2,400 $2,350 | Apr 21, 2026 |
| Barclays | Maintained | Overweight | $2,600 $2,500 | Apr 20, 2026 |
| BTIG | Reiterated | Buy | $2,400 | Apr 10, 2026 |
| Jefferies | Upgraded from Hold | Buy | $2,800 $2,600 | Apr 7, 2026 |
| BTIG | Maintained | Buy | $2,650 $2,400 | Mar 20, 2026 |
| JP Morgan | Downgraded from Overweight | Neutral | $2,650 $2,100 | Mar 12, 2026 |
| Morgan Stanley | Maintained | Overweight | $2,800 $2,600 | Mar 9, 2026 |
| JP Morgan | Maintained | Overweight | $2,800 $2,650 | Mar 2, 2026 |
| Barclays | Maintained | Overweight | $2,900 $2,600 | Feb 25, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $2,750 $2,400 | Feb 25, 2026 |
16 filings from 7 insiders · 0 buy / 0 sell over 6m
Officers and directors of MELI, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| LAWSON MARTIN RDirector | Grant | 94 | — | — | Jun 12, 2026 |
| AGUZIN ALEJANDRO NICOLASDirector | Grant | 94 | — | — | Jun 12, 2026 |
| SANDERS RICHARD ADirector | Grant | 94 | — | — | Jun 12, 2026 |
| MELAMUD MARCELOOfficer | Buy | 124 | $1604.62 | $200k | Jun 11, 2026 |
| TOLDA STELLEO PASSOSDirector | Giftindirect | 250 | — | — | Jun 10, 2026 |
| AGUZIN ALEJANDRO NICOLASDirector | Buy | 600 | $1655.01 | $994k | May 22, 2026 |
| MELAMUD MARCELOOfficer | Buy | 57 | $1755.77 | $100k | Feb 27, 2026 |
| DUBUGRAS HENRIQUE VASONCELOSDirector | Sellindirect | 845 | $2028.14 | $1.71M | Dec 12, 2025 |
| CALEMZUK EMILIANODirector | Sell | 45 | $2027.37 | $91k | Dec 11, 2025 |
| TOLDA STELLEO PASSOSDirector | Sellindirect | 246 | $2047.88 | $504k | Dec 9, 2025 |
| TOLDA STELLEO PASSOSDirector | Grant | 8 | — | — | Aug 7, 2025 |
| CALEMZUK EMILIANODirector | Grant | 64 | — | — | Aug 7, 2025 |
| LAWSON MARTIN RDirector | Grant | 64 | — | — | Aug 7, 2025 |
| AGUZIN ALEJANDRO NICOLASDirector | Grant | 64 | — | — | Aug 7, 2025 |
| SANDERS RICHARD ADirector | Grant | 64 | — | — | Aug 7, 2025 |
| CALEMZUK EMILIANODirector | Sell | 50 | $1984.98 | $99k | Nov 29, 2024 |
No analyst notes on MELI yet.
Analyst Ratings
24 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 15 | 4 | 0 | 0 | Buy1.96 |
| 1 mo ago | 4 | 15 | 5 | 0 | 0 | Buy2.04 |
| 2 mo ago | 5 | 15 | 4 | 0 | 0 | Buy1.96 |
| 3 mo ago | 5 | 15 | 4 | 0 | 0 | Buy1.96 |